Quanterix Corp (QTRX) Stock Price, Quote & News

Company Profile

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all comp...

Industry: Medical Devices

Sector: Healthcare

Phone: 617 301 9400

Website: www.quanterix.com

Address:

Building 1, 900 Middlesex Turnpike, Billerica, United States

SQUEAKSBANDIT Apr. 26 at 5:39 PM

$QTRX is there value in the merged company or will it just keep drifting lower somewheres b/t a buck and two next year ? noticed vanguard sold their entire position

0 · Reply

FlareReboot47 Apr. 25 at 6:25 AM

$QTRX Upcoming Q1 Earnings: Quanterix is scheduled to report its First Quarter 2026 financial results on May 6, 2026, after the market closes.

0 · Reply

SQUEAKSBANDIT Apr. 24 at 6:34 PM

$QTRX off the lows on very light volume seems as if the shorts took the day

0 · Reply

SQUEAKSBANDIT Apr. 21 at 7:08 PM

$QTRX took some today

0 · Reply

Rufusbird Apr. 21 at 4:37 PM

$QTRX added in low 3.20s to 3.30 new average cost 3.34

0 · Reply

anachartanalyst Apr. 20 at 5:02 PM

$QTRX https://anachart.com/wp-content/uploads/ana_temp/1776704512_soc-img.jpg

0 · Reply

Will2ride1 Apr. 17 at 4:18 PM

$QTRX back in with a starter position

0 · Reply

CHItraders Apr. 17 at 12:37 PM

$QTRX AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

0 · Reply

sakuzoh Apr. 16 at 8:14 PM

$QTRX I got fucked buying at $8 hoping for a turnaround soon..

1 · Reply

RocketThief Apr. 16 at 4:21 PM

$QTRX got a bit the other day in mid-$3S. EV is about one quarter of revenue down here and company restated that cash flow breakeven coming this year

0 · Reply

Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

Apr 17, 2026, 8:33 AM EDT - 9 days ago

AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

Apr 15, 2026, 8:33 AM EDT - 11 days ago

Quanterix Debuts Content Innovation Engine at AACR 2026

Mar 27, 2026, 4:00 PM EDT - 4 weeks ago

Quanterix Corporation Announces Date of 2026 Annual Meeting

Mar 9, 2026, 1:00 PM EDT - 6 weeks ago

Quanterix Transcript: Leerink Global Healthcare Conference 2026

Mar 4, 2026, 11:50 AM EST - 7 weeks ago

Quanterix Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 4:30 PM EST - 7 weeks ago

Quanterix Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:01 PM EST - 7 weeks ago

Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025

Mar 2, 2026, 8:33 AM EST - 7 weeks ago

Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide

Feb 26, 2026, 8:33 AM EST - 2 months ago

Quanterix to Participate in Upcoming Investor Conferences

Feb 20, 2026, 8:33 AM EST - 2 months ago

Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

Feb 3, 2026, 8:33 AM EST - 2 months ago

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection

Jan 21, 2026, 8:33 AM EST - 3 months ago

Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling

Jan 16, 2026, 4:01 PM EST - 3 months ago

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 8, 2026, 4:30 PM EST - 3 months ago

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Dec 22, 2025, 7:30 AM EST - 4 months ago

Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence

Nov 20, 2025, 4:15 PM EST - 5 months ago

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Nov 17, 2025, 5:30 PM EST - 5 months ago

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Nov 10, 2025, 4:30 PM EST - 5 months ago

Quanterix Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:01 PM EST - 5 months ago

Quanterix Releases Financial Results for the Third Quarter of 2025

Nov 3, 2025, 7:00 AM EST - 6 months ago

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

Aug 21, 2025, 4:30 PM EDT - 8 months ago

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Aug 13, 2025, 3:30 PM EDT - 9 months ago

Quanterix Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 11, 2025, 7:00 AM EDT - 9 months ago

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Quanterix Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:06 PM EDT - 9 months ago

Quanterix Releases Financial Results for the Second Quarter of 2025

Aug 4, 2025, 4:02 PM EDT - 9 months ago

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Aug 4, 2025, 9:30 AM EDT - 9 months ago

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Jul 28, 2025, 7:00 AM EDT - 9 months ago

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Jul 8, 2025, 9:07 AM EDT - 10 months ago

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Jun 23, 2025, 7:30 AM EDT - 10 months ago

Quanterix Expands Reach with IVD and Large Reference Labs

Jun 11, 2025, 8:00 AM EDT - 11 months ago

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Jun 9, 2025, 1:20 PM EDT - 11 months ago

Quanterix Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 6, 2025, 9:41 AM EDT - 11 months ago

Quanterix to Present at Goldman Sachs Global Healthcare Conference

May 23, 2025, 2:21 PM EDT - 1 year ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q1 2025

May 12, 2025, 4:01 PM EDT - 1 year ago

Quanterix Releases Financial Results for the First Quarter of 2025

May 7, 2025, 3:46 PM EDT - 1 year ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

AKYA

May 5, 2025, 7:00 AM EDT - 1 year ago

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

AKYA

Apr 29, 2025, 7:00 AM EDT - 1 year ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

AKYA

Apr 7, 2025, 8:15 AM EDT - 1 year ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

AKYA

Apr 1, 2025, 1:00 AM EDT - 1 year ago

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Mar 17, 2025, 4:00 PM EDT - 1 year ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

AKYA

Mar 13, 2025, 1:00 PM EDT - 1 year ago

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 11, 2025, 8:00 AM EDT - 1 year ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Mar 3, 2025, 8:00 AM EST - 1 year ago

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Mar 3, 2025, 6:00 AM EST - 1 year ago

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Mar 2, 2025, 11:00 AM EST - 1 year ago

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Feb 19, 2025, 8:30 AM EST - 1 year ago

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Feb 18, 2025, 3:40 PM EST - 1 year ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

AKYA

Feb 14, 2025, 5:48 PM EST - 1 year ago

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Jan 15, 2025, 7:30 PM EST - 1 year ago

Quanterix Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 10, 2025, 8:30 AM EST - 1 year ago

Quanterix Transcript: M&A Announcement

Nov 12, 2024, 4:30 PM EST - 1 year ago

Quanterix Earnings Call Transcript: Q3 2024

Sep 6, 2024, 1:50 PM EDT - 1 year ago

Quanterix Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 13, 2024, 3:00 PM EDT - 1 year ago

Quanterix Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q2 2024

Jun 12, 2024, 2:40 PM EDT - 2 years ago

Quanterix Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 8, 2024, 8:30 AM EDT - 2 years ago

Quanterix Earnings Call Transcript: Q1 2024

Mar 25, 2024, 4:00 PM EDT - 2 years ago

Quanterix Transcript: Investor Update

Mar 4, 2024, 12:50 PM EST - 2 years ago

Quanterix Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 29, 2024, 4:30 PM EST - 2 years ago

Quanterix Earnings Call Transcript: Q4 2023

Jan 10, 2024, 8:15 PM EST - 2 years ago

Quanterix Transcript: J.P. Morgan 2024 42nd Annual Healthcare Conference

Nov 7, 2023, 8:30 AM EST - 2 years ago

Quanterix Earnings Call Transcript: Q3 2023

Oct 3, 2023, 12:15 PM EDT - 2 years ago

Quanterix Transcript: Goldman Sachs Alzheimer’s Disease Day

Sep 13, 2023, 3:35 PM EDT - 2 years ago

Quanterix Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Aug 10, 2023, 12:00 PM EDT - 2 years ago

Quanterix Transcript: Canaccord Genuity 43rd Annual Growth Conference

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Quanterix Earnings Call Transcript: Q2 2023

May 9, 2023, 4:30 PM EDT - 3 years ago

Quanterix Earnings Call Transcript: Q1 2023

Mar 15, 2023, 4:35 PM EDT - 3 years ago

Quanterix Transcript: Barclays Global Healthcare Conference

Mar 6, 2023, 8:30 AM EST - 3 years ago

Quanterix Earnings Call Transcript: Q4 2022

Jan 12, 2023, 3:00 PM EST - 3 years ago

Quanterix Transcript: JPMorgan Healthcare Conference

Nov 8, 2022, 1:30 PM EST - 3 years ago

Quanterix Earnings Call Transcript: Q3 2022

Aug 8, 2022, 12:27 AM EDT - 4 years ago

Quanterix Earnings Call Transcript: Q2 2022

May 10, 2022, 5:59 AM EDT - 4 years ago

Quanterix Earnings Call Transcript: Q1 2022

Mar 1, 2022, 10:55 AM EST - 4 years ago

Quanterix Earnings Call Transcript: Q4 2021

Nov 3, 2021, 8:00 PM EDT - 4 years ago

Quanterix Earnings Call Transcript: Q3 2021

Aug 4, 2021, 8:00 PM EDT - 5 years ago

Quanterix Earnings Call Transcript: Q2 2021

May 5, 2021, 1:38 PM EDT - 5 years ago

Quanterix Earnings Call Transcript: Q1 2021

Mar 2, 2021, 4:30 PM EST - 5 years ago

Quanterix Earnings Call Transcript: Q4 2020

Nov 5, 2020, 4:30 PM EST - 5 years ago

Quanterix Earnings Call Transcript: Q3 2020

Aug 4, 2020, 5:00 PM EDT - 6 years ago

Quanterix Earnings Call Transcript: Q2 2020

May 5, 2020, 4:30 PM EDT - 6 years ago

Quanterix Earnings Call Transcript: Q1 2020

Mar 13, 2020, 8:00 AM EDT - 6 years ago

Quanterix Earnings Call Transcript: Q4 2019

Nov 6, 2019, 4:30 PM EST - 7 years ago

Quanterix Earnings Call Transcript: Q3 2019

Aug 6, 2019, 10:00 AM EDT - 7 years ago

Quanterix Earnings Call Transcript: Q2 2019

Jun 26, 2019, 5:00 PM EDT - 7 years ago

Quanterix Transcript: M&A Announcement

May 9, 2019, 4:30 PM EDT - 7 years ago

Quanterix Earnings Call Transcript: Q1 2019

Mar 7, 2019, 4:30 PM EST - 7 years ago

Quanterix Earnings Call Transcript: Q4 2018

Nov 1, 2018, 4:30 PM EDT - 8 years ago

Quanterix Earnings Call Transcript: Q3 2018

Aug 8, 2018, 4:30 PM EDT - 8 years ago

Quanterix Earnings Call Transcript: Q2 2018

May 9, 2018, 4:30 PM EDT - 8 years ago

Quanterix Earnings Call Transcript: Q1 2018

SQUEAKSBANDIT Apr. 26 at 5:39 PM

$QTRX is there value in the merged company or will it just keep drifting lower somewheres b/t a buck and two next year ? noticed vanguard sold their entire position

0 · Reply

FlareReboot47 Apr. 25 at 6:25 AM

$QTRX Upcoming Q1 Earnings: Quanterix is scheduled to report its First Quarter 2026 financial results on May 6, 2026, after the market closes.

0 · Reply

SQUEAKSBANDIT Apr. 24 at 6:34 PM

$QTRX off the lows on very light volume seems as if the shorts took the day

0 · Reply

SQUEAKSBANDIT Apr. 21 at 7:08 PM

$QTRX took some today

0 · Reply

Rufusbird Apr. 21 at 4:37 PM

$QTRX added in low 3.20s to 3.30 new average cost 3.34

0 · Reply

anachartanalyst Apr. 20 at 5:02 PM

$QTRX https://anachart.com/wp-content/uploads/ana_temp/1776704512_soc-img.jpg

0 · Reply

Will2ride1 Apr. 17 at 4:18 PM

$QTRX back in with a starter position

0 · Reply

CHItraders Apr. 17 at 12:37 PM

$QTRX AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

0 · Reply

sakuzoh Apr. 16 at 8:14 PM

$QTRX I got fucked buying at $8 hoping for a turnaround soon..

1 · Reply

RocketThief Apr. 16 at 4:21 PM

$QTRX got a bit the other day in mid-$3S. EV is about one quarter of revenue down here and company restated that cash flow breakeven coming this year

0 · Reply

focafoca99 Apr. 15 at 2:24 PM

$QTRX introduced its new Content Innovation Engine at AACR as part of its expanded spatial biology and immunoassay platform strategy.

0 · Reply

SQUEAKSBANDIT Apr. 11 at 2:02 AM

$QTRX oversold a trade back to 5 is a 50% move woh

0 · Reply

Will2ride1 Apr. 10 at 1:47 PM

$QTRX waiting and watching closely for this to bottom from that nasty H&S pattern

0 · Reply

Rufusbird Apr. 9 at 1:45 PM

$QTRX doubled my position here at $3.38 average cost now $3.57.

1 · Reply

SQUEAKSBANDIT Apr. 8 at 11:33 PM

$QTRX been out for a bit took some today the technology is attractive in the final analysis im thinking there will be several bids for the company

0 · Reply

CaptainAmrica Apr. 8 at 9:34 PM

$QTRX... The new Alzheimer blood test if successful will be a game changer...Already received FDA Breakthrough designation.... Been buying the dips...New Ceo, Ian Cunningham has history of turning company around with ILMN and EXAS....

1 · Reply

OfficialStocktwitsUser Apr. 2 at 11:47 AM

$QTRX RSI: 13.64, MACD: -0.6066 Vol: 0.61, MA20: 4.36, MA50: 5.49 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

CaptainAmrica Mar. 25 at 4:33 PM

$QTRX... Initiated... Speculation play with long term potential.

0 · Reply

Sami2021 Mar. 24 at 2:50 PM

$QTRX down 50% in less than 1 month!??! over what???

0 · Reply

Rufusbird Mar. 24 at 2:44 PM

$QTRX bot back in at 3.75 I think window dressing pressure is big factor on this weeks price pressure.

0 · Reply

ImadogImaMut Mar. 24 at 1:25 PM

$QTRX Sold but Still I will be back

0 · Reply

LQQKER_INSIDER Mar. 24 at 5:44 AM

$QTRX Someone let me know when it's trading at half of cash. 💤

1 · Reply

Market Cap	153.96M
Revenue (ttm)	138.90M
Net Income (ttm)	-107.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-77.14%
Debt to Equity Ratio	0.00

Volume	713,300
Avg Vol	808,334
Day's Range	N/A - N/A
Shares Out	46.94M
Stochastic %K	36%
Beta	1.32
Analysts	Hold
Price Target	$5.33